Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Armand

Showing results (11-20 of 273) with videos related to

Pageof 28
Sort By:
Best Practice & Research. Clinical Haematology|September 15, 2018
Immunotherapy in aggressive B-cell lymphomasCaron A Jacobson, Philippe Armand
Surgical Oncology Clinics of North America|November 24, 2019
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and TreatmentJennifer L Crombie, Philippe Armand
British Journal of Haematology|October 28, 2017
Minimal residual disease in non-Hodgkin lymphoma - current applications and future directionsMatthew L Chase, Philippe Armand
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2017
Minimal Residual Disease Assessment in Lymphoma: Methods and ApplicationsAlex F Herrera, Philippe Armand
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Allogeneic stem cell transplantation for aplastic anemiaPhilippe Armand, Joseph H Antin
Hematology/Oncology Clinics of North America|June 24, 2019
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and TreatmentJennifer L Crombie, Philippe Armand
Current Hematologic Malignancy Reports|February 4, 2017
Immune Checkpoint Blockade and Hematopoietic Stem Cell TransplantReid W Merryman, Philippe Armand
Blood|September 24, 2024
The current landscape of frontline large B-cell lymphoma trialsDavid Qualls, Philippe Armand, Gilles Salles
European Journal of Cancer (Oxford, England : 1990)|April 14, 2020
Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphomaRoch Houot, Philippe Armand, Caron A Jacobson
Leukemia & Lymphoma|January 10, 2020
Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphomaArushi Khurana, Philippe Armand, Stephen M Ansell
Pageof 28

Showing results (11-20 of 273) with videos related to

Sort By:
Pageof 28
Best Practice & Research. Clinical Haematology|September 15, 2018
Immunotherapy in aggressive B-cell lymphomasCaron A Jacobson, Philippe Armand
Surgical Oncology Clinics of North America|November 24, 2019
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and TreatmentJennifer L Crombie, Philippe Armand
British Journal of Haematology|October 28, 2017
Minimal residual disease in non-Hodgkin lymphoma - current applications and future directionsMatthew L Chase, Philippe Armand
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2017
Minimal Residual Disease Assessment in Lymphoma: Methods and ApplicationsAlex F Herrera, Philippe Armand
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Allogeneic stem cell transplantation for aplastic anemiaPhilippe Armand, Joseph H Antin
Hematology/Oncology Clinics of North America|June 24, 2019
Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and TreatmentJennifer L Crombie, Philippe Armand
Current Hematologic Malignancy Reports|February 4, 2017
Immune Checkpoint Blockade and Hematopoietic Stem Cell TransplantReid W Merryman, Philippe Armand
Blood|September 24, 2024
The current landscape of frontline large B-cell lymphoma trialsDavid Qualls, Philippe Armand, Gilles Salles
European Journal of Cancer (Oxford, England : 1990)|April 14, 2020
Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphomaRoch Houot, Philippe Armand, Caron A Jacobson
Leukemia & Lymphoma|January 10, 2020
Checkpoint inhibition therapy as possible frontline therapy for Hodgkin lymphomaArushi Khurana, Philippe Armand, Stephen M Ansell
Pageof 28